[{"id":"d94de171-8220-41f2-8706-22ba38f8e320","acronym":"ETAPA I","url":"https://clinicaltrials.gov/study/NCT05283109","created_at":"2022-03-16T15:54:21.194Z","updated_at":"2024-07-02T16:35:37.647Z","phase":"Phase 1","brief_title":"ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM","source_id_and_acronym":"NCT05283109 - ETAPA I","lead_sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","biomarkers":" MGMT • BIRC5","pipe":" | ","alterations":" IDH wild-type","tags":["MGMT • BIRC5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Hiltonol (poly-ICLC) • P30-EPS"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 08/30/2023","start_date":" 08/30/2023","primary_txt":" Primary completion: 04/01/2025","primary_completion_date":" 04/01/2025","study_txt":" Completion: 02/01/2028","study_completion_date":" 02/01/2028","last_update_posted":"2023-09-08"}]